- Home
- PAVS vs CRBP Comparison
PAVS vs CRBP Comparison
Compare PAVS & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- CRBP
- Stock Information
- Founded
- PAVS 2004
- CRBP 2009
- Country
- PAVS United States
- CRBP United States
- Employees
- PAVS N/A
- CRBP N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- CRBP Health Care
- Exchange
- PAVS Nasdaq
- CRBP Nasdaq
- Market Cap
- PAVS 89.6M
- CRBP 73.4M
- IPO Year
- PAVS 2019
- CRBP N/A
- Fundamental
- Price
- PAVS $1.03
- CRBP $6.45
- Analyst Decision
- PAVS
- CRBP Strong Buy
- Analyst Count
- PAVS 0
- CRBP 10
- Target Price
- PAVS N/A
- CRBP $53.56
- AVG Volume (30 Days)
- PAVS 26.8K
- CRBP 147.8K
- Earning Date
- PAVS 01-01-0001
- CRBP 05-06-2025
- Dividend Yield
- PAVS N/A
- CRBP N/A
- EPS Growth
- PAVS N/A
- CRBP N/A
- EPS
- PAVS N/A
- CRBP N/A
- Revenue
- PAVS $6,613,273.00
- CRBP N/A
- Revenue This Year
- PAVS N/A
- CRBP N/A
- Revenue Next Year
- PAVS N/A
- CRBP $150.00
- P/E Ratio
- PAVS N/A
- CRBP N/A
- Revenue Growth
- PAVS 2.50
- CRBP N/A
- 52 Week Low
- PAVS $0.32
- CRBP $4.64
- 52 Week High
- PAVS $1.50
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- PAVS 17.87
- CRBP 46.87
- Support Level
- PAVS $1.22
- CRBP $6.10
- Resistance Level
- PAVS $1.40
- CRBP $8.07
- Average True Range (ATR)
- PAVS 0.06
- CRBP 0.71
- MACD
- PAVS -0.03
- CRBP -0.10
- Stochastic Oscillator
- PAVS 6.40
- CRBP 13.31
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.